The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02504372
Brief Title: Study of Pembrolizumab (MK-3475) vs Placebo for Participants With Non-small Cell Lung Cancer After Resection With or Without Standard Adjuvant Therapy (MK-3475-091/KEYNOTE-091) (PEARLS)

First Submitted : July 20, 2015
First Submitted that Met QC Criteria : July 20, 2015
First Posted : July 21, 2015 (Estimate)

Results First Submitted : January 9, 2024
Results First Submitted that Met QC Criteria : February 13, 2024
Results First Posted : February 15, 2024

Last Update Submitted that Met QC Criteria : February 13, 2024
Last Update Posted : February 15, 2024